Scotiabank Begins Coverage on Innoviva (NASDAQ:INVA)
Scotiabank began coverage on shares of Innoviva (NASDAQ:INVA – Free Report) in a research report released on Friday morning, MarketBeat Ratings reports. The brokerage issued a sector outperform rating and a $55.00 target price on the biotechnology company’s stock. Separately, StockNews.com cut Innoviva from a “buy” rating to a “hold” rating in a research report […]
Scotiabank began coverage on shares of Innoviva (NASDAQ:INVA – Free Report) in a research report released on Friday morning, MarketBeat Ratings reports. The brokerage issued a sector outperform rating and a $55.00 target price on the biotechnology company’s stock. Separately, StockNews.com cut Innoviva from a “buy” rating to a “hold” rating in a research report […]
